---
type: "NewsArticle"
title: "Glutamine did not change mood or cognition during brief simulated high-altitude exposure"
description: "In a randomized trial of young men, six hours of simulated hypoxia at 4,500 m did not alter psychobiological measures, and glutamine supplementation did not produce a detectable benefit."
resource: "https://nootropikler.com/news/glutamine-hypoxia-cognition-rct"
tags: ["supplements", "cognition", "research"]
timestamp: 2026-10-05T01:04:23Z
language: "en"
---

# Glutamine did not change mood or cognition during brief simulated high-altitude exposure

In a randomized trial of young men, six hours of simulated hypoxia at 4,500 m did not alter psychobiological measures, and glutamine supplementation did not produce a detectable benefit.

Author: Nootropik News Editorial Team
Published: 2026-10-05T01:04:23Z
Update: 2026-10-05T01:04:23Z
News/source date: 2026-08-25
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

Researchers randomized young men aged 20–30 years to glutamine or placebo before six hours of exposure to simulated altitude equivalent to 4,500 m. The double-masked trial assessed mood and cognitive performance alongside physiological measures.

## Findings

The paper’s title and reported conclusion state that hypoxia did not affect the measured psychobiological parameters and that this was unchanged by glutamine. The study therefore found no evidence that the supplement protected tested cognitive or mood outcomes in this short exposure.

## Limits and disclosures

The sample was limited to young men and a brief laboratory exposure; results do not address longer stays at altitude, other groups or other uses of glutamine. This does not establish a general lack of effect for every setting.

## Sources

- [Six hours of hypoxia at 4500 m does not affect psychobiological parameters, regardless of glutamine supplementation: A randomized, double-masked, placebo-controlled clinical trial](https://doi.org/10.1177/02601060261480418) — 2026-08-25
